- Home
- PRTA vs DMLP Comparison
PRTA vs DMLP Comparison
Compare PRTA & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- DMLP
- Stock Information
- Founded
- PRTA 2012
- DMLP 2003
- Country
- PRTA Ireland
- DMLP United States
- Employees
- PRTA N/A
- DMLP N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- DMLP Oil & Gas Production
- Sector
- PRTA Health Care
- DMLP Energy
- Exchange
- PRTA Nasdaq
- DMLP Nasdaq
- Market Cap
- PRTA 1.2B
- DMLP 1.2B
- IPO Year
- PRTA N/A
- DMLP N/A
- Fundamental
- Price
- PRTA $21.89
- DMLP $30.34
- Analyst Decision
- PRTA Buy
- DMLP
- Analyst Count
- PRTA 7
- DMLP 0
- Target Price
- PRTA $58.83
- DMLP N/A
- AVG Volume (30 Days)
- PRTA 255.3K
- DMLP 50.6K
- Earning Date
- PRTA 10-31-2024
- DMLP 10-31-2024
- Dividend Yield
- PRTA N/A
- DMLP 9.41%
- EPS Growth
- PRTA N/A
- DMLP N/A
- EPS
- PRTA N/A
- DMLP 2.64
- Revenue
- PRTA $217,246,000.00
- DMLP $155,576,000.00
- Revenue This Year
- PRTA $59.66
- DMLP N/A
- Revenue Next Year
- PRTA N/A
- DMLP N/A
- P/E Ratio
- PRTA N/A
- DMLP $11.31
- Revenue Growth
- PRTA 276.98
- DMLP 5.73
- 52 Week Low
- PRTA $18.69
- DMLP $27.16
- 52 Week High
- PRTA $55.89
- DMLP $35.74
- Technical
- Relative Strength Index (RSI)
- PRTA 58.55
- DMLP 47.02
- Support Level
- PRTA $20.15
- DMLP $28.57
- Resistance Level
- PRTA $22.83
- DMLP $30.40
- Average True Range (ATR)
- PRTA 0.82
- DMLP 0.60
- MACD
- PRTA 0.13
- DMLP -0.02
- Stochastic Oscillator
- PRTA 82.66
- DMLP 53.56
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.